EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-13.89%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$4.5B
AUM Growth
-$744M
(-14%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
18.83%
Holding
979
New
48
Increased
192
Reduced
136
Closed
31
Top Buys
| 1 |
HES
Hess
HES
|
$32.2M |
| 2 |
Netflix
NFLX
|
$31.3M |
| 3 |
Pfizer
PFE
|
$14.6M |
| 4 |
Coca-Cola
KO
|
$12.1M |
| 5 |
East-West Bancorp
EWBC
|
$9.42M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$32.2M |
| 2 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
$19.3M |
| 3 |
VMW
VMware, Inc
VMW
|
$15.3M |
| 4 |
Coterra Energy
CTRA
|
$12.9M |
| 5 |
Essential Utilities
WTRG
|
$11.4M |
Sector Composition
| 1 | Technology | 29.9% |
| 2 | Healthcare | 19.98% |
| 3 | Consumer Discretionary | 10.77% |
| 4 | Financials | 9.62% |
| 5 | Industrials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $1.01M | 0.02% |
13,650
-6,100
| -31% | -$449K |
|
352
United Natural Foods
UNFI
$1.75B
| $979K | 0.02% |
24,644
+1,500
| +6% | +$59.6K |
|
353
STAAR Surgical
STAA
$1.38B
| $967K | 0.02% |
13,153
+350
| +3% | +$25.7K |
|
354
Verisk Analytics
VRSK
$37.8B
| $967K | 0.02% |
5,700
+700
| +14% | +$119K |
|
|
MRO
355
DELISTED
Marathon Oil Corporation
MRO
| $964K | 0.02% |
42,320
+4,224
| +11% | +$96.3K |
|
356
Intel
INTC
$107B
| $958K | 0.02% |
25,659
-168,005
| -87% | -$6.27M |
|
357
Insmed
INSM
$30.7B
| $955K | 0.02% |
47,600
| – | – |
|
358
Stride
LRN
$7.01B
| $954K | 0.02% |
23,100
| – | – |
|
359
Kimco Realty
KIM
$15.4B
| $948K | 0.02% |
+47,000
| New | +$948K |
|
|
B
360
Barrick Mining Corporation
B
$48.5B
| $948K | 0.02% |
53,600
| – | – |
|
|
SAGE
361
DELISTED
Sage Therapeutics
SAGE
| $935K | 0.02% |
28,500
| – | – |
|
362
Canadian Natural Resources
CNQ
$63.2B
| $925K | 0.02% |
34,714
-26,546
| -43% | -$707K |
|
363
Freeport-McMoran
FCX
$66.5B
| $922K | 0.02% |
30,600
-121,000
| -80% | -$3.65M |
|
364
Aflac
AFL
$57.2B
| $921K | 0.02% |
16,600
-3,100
| -16% | -$172K |
|
|
CCXI
365
DELISTED
ChemoCentryx, Inc.
CCXI
| $905K | 0.02% |
35,500
| – | – |
|
366
Ultragenyx Pharmaceutical
RARE
$3.07B
| $904K | 0.02% |
15,010
| – | – |
|
367
Nucor
NUE
$33.8B
| $903K | 0.02% |
8,500
+3,400
| +67% | +$361K |
|
368
Autoliv
ALV
$9.58B
| $901K | 0.02% |
12,118
+750
| +7% | +$55.8K |
|
369
Cytokinetics
CYTK
$6.34B
| $899K | 0.02% |
18,450
| – | – |
|
|
KRTX
370
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $884K | 0.02% |
7,070
| – | – |
|
371
Travere Therapeutics
TVTX
$1.93B
| $879K | 0.02% |
35,600
| – | – |
|
372
Philip Morris
PM
$251B
| $876K | 0.02% |
8,875
-11,055
| -55% | -$1.09M |
|
373
iShares MSCI ACWI ETF
ACWI
$22.1B
| $876K | 0.02% |
10,360
| – | – |
|
374
NIO
NIO
$13.4B
| $874K | 0.02% |
40,000
-78,820
| -66% | -$1.72M |
|
375
Arvinas
ARVN
$575M
| $873K | 0.02% |
20,000
| – | – |
|